Hansen's disease, also known as leprosy, is a chronic bacterial disease that primarily affects the skin, peripheral nerves and upper airway. Feared as a highly contagious and devastating disease, it is well established that Hansen's disease (leprosy) is not highly transmissible, is very treatable, and, with early diagnosis and treatment, is not disabling. Compiled statistics reveal that Hansen's disease (leprosy) is rare in the U.S. There are currently approximately 6,500 cases; about 3,300 require active medical management.
Leprosy Is Not Eliminated and It Is Not Simple
This webinar will describe the major clinical features suggesting Hansen’s Disease, describe how to confirm the diagnosis and, if necessary, refer patients for confirmation, and describe basic management of Hansen’s Disease. The webinar was recorded from a live presentation from April 1, 2016 in Phoenix, Arizona.
The National Hansen's Disease Program, which is under the Health Resources and Services Administration, is the epicenter of Hansen's disease (leprosy) care, research and information in the U.S. The program cares for patients at the Ochsner Medical Center in Baton Rouge, oversees an ambulatory care network with clinics throughout the United States and Puerto Rico and makes referrals for treatment, consults with private sector providers and accepts referrals for patients with Hansen's disease (leprosy)-related complications, and advances treatment and educates medical professionals about Hansen's disease (leprosy).
David Scollard, MD, PhD
Director, National Hansen’s Disease Program
Register through Dignity Health
Brought to you by: Dignity Health
HRSA’s Office of Regional Operations Region IX, CAPT Nidhi Jain, MD, MPH
The Office of Regional Operations works to improve health equity in underserved communities through on-the-ground outreach, education, technical assistance and partnering with local, state and federal organizations.